Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Vertex Europe (UK) by Year
Vertex Europe (UK) — Foreign exchange gain (loss) ($M) ($M)
Vertex Pharmaceuticals Vertex Europe (UK): -$7.20M in FY2025, down 76.1% from a year earlier.
Where the FY2025 figure comes from
“Foreign exchange gain/(loss) (7,238) (30,051)”
Source: Vertex Pharmaceuticals (Europe) Limited (02907620) ↗
Reported in UK Companies House Statutory Accounts (02907620, OCR).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vertex Europe (UK) — Foreign exchange gain (loss) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -7.20 | -76.1% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2024 | Dec 31, 2024 | -30.1 | -252.0% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2023 | Dec 31, 2023 | 19.8 | -175.9% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2022 | Dec 31, 2022 | -26.1 | -241.1% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2021 | Dec 31, 2021 | 18.5 | -156.4% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2020 | Dec 31, 2020 | -32.8 | -963.2% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2019 | Dec 31, 2019 | 3.80 | -272.7% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2018 | Dec 31, 2018 | -2.20 | – | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Vertex Europe (UK) ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/uk-eur-fx-gain-loss
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.